. (KITE)
$179.79 - (-)
Market Cap: -
As of 07/22/19 12:00 AM EDT. Market closed.
. (KITE)
$179.79
- (-)
Market Cap: -
As of 07/22/19 12:00 AM EDT. Market closed.
Add to Portfolio
COMPANY PROFILE
Sector
Industry
URL
Address
.
Sector
Industry
URL
Address
.
PRICE CHART FOR
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
-
Previous Close
$179.79
Days Range
- - -
52 week range
- - -
Volume
0
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
0
Open
-
Previous Close
$179.79
Days Range
- - -
52 week range
- - -
Volume
0
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
0
FINANCIAL STATEMENTS FOR
LOADING...
INSIDER TRANSACTIONS FOR
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
Peacock Jonathan M | Director | Oct 03, 2017 | Option Exercise | $180.00 | 67,932 | 12,227,760 | 1,807 | Oct 05, 2017, 08:28 PM |
CLARK IAN T | Director | Oct 03, 2017 | Option Exercise | $180.00 | 1,776 | 319,680 | 5,324 | Oct 05, 2017, 08:27 PM |
Kazam Joshua A | Director | Oct 03, 2017 | Option Exercise | $180.00 | 70,050 | 12,609,000 | 0 | Oct 05, 2017, 08:25 PM |
Kazam Joshua A | Director | Oct 03, 2017 | Option Exercise | $180.00 | 2,553 | 459,540 | 1,807 | Oct 05, 2017, 08:25 PM |
Humer Franz B | Director | Oct 03, 2017 | Option Exercise | $180.00 | 4,624 | 832,320 | 1,807 | Oct 05, 2017, 08:24 PM |
DOUMANI ROY | Director | Oct 03, 2017 | Option Exercise | $180.00 | 150,620 | 27,111,600 | 1,807 | Oct 05, 2017, 08:23 PM |
DOUMANI ROY | Director | Oct 03, 2017 | Option Exercise | $180.00 | 25,065 | 4,511,700 | 0 | Oct 05, 2017, 08:23 PM |
CHAMPSI FARAH | Director | Oct 03, 2017 | Option Exercise | $180.00 | 61,467 | 11,064,060 | 1,807 | Oct 05, 2017, 08:20 PM |
WITTE OWEN N. | Director | Oct 03, 2017 | Option Exercise | $180.00 | 58,535 | 10,536,300 | 5,715 | Oct 05, 2017, 08:19 PM |
MOORE TIMOTHY L. | EVP, Technical Operations | Oct 03, 2017 | Option Exercise | $180.00 | 3,927 | 706,860 | 41,734 | Oct 05, 2017, 08:17 PM |
Tomasello Shawn | Chief Commercial Officer | Oct 03, 2017 | Option Exercise | $180.00 | 16,135 | 2,904,300 | 39,933 | Oct 05, 2017, 08:16 PM |
Wiezorek Jeffrey | SVP Clinical Development | Oct 03, 2017 | Option Exercise | $180.00 | 14,674 | 2,641,320 | 11,150 | Oct 05, 2017, 08:15 PM |
Kim Helen Susan | EVP, Business Development | Oct 03, 2017 | Option Exercise | $180.00 | 4,193 | 754,740 | 17,500 | Oct 05, 2017, 08:14 PM |
JENKINSON PAUL L | Chief Financial Officer | Oct 03, 2017 | Option Exercise | $180.00 | 3,000 | 540,000 | 0 | Oct 05, 2017, 08:13 PM |
Chang David D | EVP, R&D, Chief Medical Off. | Oct 03, 2017 | Option Exercise | $180.00 | 16,605 | 2,988,900 | 38,675 | Oct 05, 2017, 08:12 PM |
Belldegrun Arie | Chairman, President and CEO | Oct 03, 2017 | Option Exercise | $180.00 | 3,197,269 | 575,508,420 | 0 | Oct 05, 2017, 08:10 PM |
Tomasello Shawn | Chief Commercial Officer | Sep 25, 2017 | Sale | $179.66 | 4,203 | 755,128 | 61,068 | Sep 27, 2017, 09:44 PM |
Kim Helen Susan | EVP, Business Development | Sep 25, 2017 | Sale | $179.66 | 3,171 | 569,715 | 21,693 | Sep 27, 2017, 09:43 PM |
MOORE TIMOTHY L. | EVP, Technical Operations | Sep 25, 2017 | Sale | $179.66 | 4,228 | 759,619 | 45,661 | Sep 27, 2017, 09:42 PM |
MOORE TIMOTHY L. | EVP, Technical Operations | Mar 15, 2017 | Sale | $83.31 | 7,511 | 625,741 | 41,889 | Sep 27, 2017, 09:42 PM |
Wiezorek Jeffrey | SVP Clinical Development | Sep 25, 2017 | Sale | $179.66 | 5,283 | 949,165 | 25,824 | Sep 27, 2017, 09:41 PM |
Chang David D | EVP, R&D, Chief Medical Off. | Sep 25, 2017 | Sale | $179.66 | 7,927 | 1,424,197 | 57,423 | Sep 27, 2017, 09:40 PM |
JENKINSON PAUL L | Chief Financial Officer | Sep 25, 2017 | Sale | $179.66 | 948 | 170,321 | 9,462 | Sep 27, 2017, 09:39 PM |
BUTITTA CYNTHIA M | Chief Operating Officer | Sep 25, 2017 | Sale | $179.66 | 4,228 | 759,619 | 121,567 | Sep 27, 2017, 09:38 PM |
Belldegrun Arie | Chairman, President and CEO | Sep 25, 2017 | Sale | $179.66 | 26,347 | 4,733,607 | 109,160 | Sep 27, 2017, 09:38 PM |
Kim Helen Susan | EVP, Business Development | Aug 10, 2017 | Option Exercise | $52.85 | 6,251 | 330,369 | 24,915 | Aug 14, 2017, 05:04 PM |
Kim Helen Susan | EVP, Business Development | Aug 10, 2017 | Sale | $120.09 | 6,251 | 750,683 | 18,664 | Aug 14, 2017, 05:04 PM |
BUTITTA CYNTHIA M | Chief Operating Officer | Aug 10, 2017 | Option Exercise | $1.35 | 15,000 | 20,250 | 132,795 | Aug 14, 2017, 05:03 PM |
BUTITTA CYNTHIA M | Chief Operating Officer | Aug 10, 2017 | Sale | $120.72 | 15,000 | 1,810,758 | 123,595 | Aug 14, 2017, 05:03 PM |
Kim Helen Susan | EVP, Business Development | Aug 08, 2017 | Option Exercise | $53.90 | 79,949 | 4,309,251 | 98,613 | Aug 10, 2017, 04:57 PM |
Kim Helen Susan | EVP, Business Development | Aug 08, 2017 | Sale | $119.56 | 79,949 | 9,558,324 | 87,539 | Aug 10, 2017, 04:57 PM |
MOORE TIMOTHY L. | EVP, Technical Operations | Aug 03, 2017 | Option Exercise | $44.91 | 6,000 | 269,460 | 55,400 | Aug 04, 2017, 07:50 PM |
MOORE TIMOTHY L. | EVP, Technical Operations | Aug 03, 2017 | Sale | $110.06 | 6,000 | 660,343 | 54,531 | Aug 04, 2017, 07:50 PM |
MOORE TIMOTHY L. | EVP, Technical Operations | Aug 01, 2017 | Option Exercise | $44.91 | 3,000 | 134,730 | 61,400 | Aug 03, 2017, 09:14 PM |
MOORE TIMOTHY L. | EVP, Technical Operations | Aug 01, 2017 | Sale | $107.69 | 12,000 | 1,292,322 | 58,923 | Aug 03, 2017, 09:14 PM |
Kim Helen Susan | EVP, Business Development | Jul 31, 2017 | Option Exercise | $52.96 | 26,649 | 1,411,437 | 45,313 | Aug 01, 2017, 07:00 PM |
Kim Helen Susan | EVP, Business Development | Jul 31, 2017 | Sale | $109.28 | 26,649 | 2,912,272 | 29,509 | Aug 01, 2017, 07:00 PM |
BUTITTA CYNTHIA M | Chief Operating Officer | Jul 10, 2017 | Option Exercise | $1.35 | 15,000 | 20,250 | 132,795 | Jul 11, 2017, 05:36 PM |
BUTITTA CYNTHIA M | Chief Operating Officer | Jul 10, 2017 | Sale | $103.09 | 15,000 | 1,546,300 | 129,448 | Jul 11, 2017, 05:36 PM |
Wiezorek Jeffrey | SVP Clinical Development | Jul 03, 2017 | Option Exercise | $6.89 | 10,000 | 68,900 | 31,071 | Jul 06, 2017, 06:15 PM |
Wiezorek Jeffrey | SVP Clinical Development | Jul 03, 2017 | Sale | $104.32 | 10,000 | 1,043,201 | 22,272 | Jul 06, 2017, 06:15 PM |
BUTITTA CYNTHIA M | Chief Operating Officer | Jun 23, 2017 | Option Exercise | $1.35 | 5,000 | 6,750 | 122,795 | Jun 27, 2017, 07:07 PM |
BUTITTA CYNTHIA M | Chief Operating Officer | Jun 23, 2017 | Sale | $100.81 | 5,000 | 504,033 | 119,845 | Jun 27, 2017, 07:07 PM |
BUTITTA CYNTHIA M | Chief Operating Officer | Jun 23, 2017 | Sale | $100.81 | 5,000 | 504,033 | 114,845 | Jun 27, 2017, 12:25 PM |
WITTE OWEN N. | Director | Jun 23, 2017 | Option Exercise | $18.00 | 12,500 | 225,000 | 101,250 | Jun 26, 2017, 07:55 PM |
WITTE OWEN N. | Director | Jun 26, 2017 | Sale | $100.60 | 12,500 | 1,257,500 | 76,250 | Jun 26, 2017, 07:55 PM |
WITTE OWEN N. | Director | Jun 23, 2017 | Sale | $100.00 | 12,500 | 1,250,000 | 88,750 | Jun 26, 2017, 07:55 PM |
Ruchefsky Steven B | Director | Jun 14, 2017 | Sale | $89.48 | 20,000 | 1,789,574 | 205,426 | Jun 16, 2017, 05:43 PM |
CHAMPSI FARAH | Director | Jun 16, 2017 | Sale | $88.11 | 5,450 | 480,200 | 0 | Jun 16, 2017, 05:41 PM |
CHAMPSI FARAH | Director | Jun 14, 2017 | Sale | $90.40 | 15,000 | 1,356,000 | 63,664 | Jun 16, 2017, 05:41 PM |
BUTITTA CYNTHIA M | Chief Operating Officer | Jun 09, 2017 | Option Exercise | $1.35 | 10,000 | 13,500 | 127,795 | Jun 12, 2017, 07:16 PM |
BUTITTA CYNTHIA M | Chief Operating Officer | Jun 09, 2017 | Sale | $88.55 | 10,000 | 885,491 | 127,395 | Jun 12, 2017, 07:16 PM |
DOUMANI ROY | Director | Jun 08, 2017 | Sale | $84.53 | 5,000 | 422,634 | 150,017 | Jun 09, 2017, 09:11 PM |
DOUMANI ROY | Director | Jun 07, 2017 | Sale | $84.46 | 10,000 | 844,621 | 155,017 | Jun 09, 2017, 09:11 PM |
Kim Helen Susan | EVP, Business Development | Jun 01, 2017 | Option Exercise | $51.43 | 2,400 | 123,432 | 21,064 | Jun 05, 2017, 05:05 PM |
Kim Helen Susan | EVP, Business Development | Jun 01, 2017 | Sale | $72.45 | 2,400 | 173,880 | 18,664 | Jun 05, 2017, 05:05 PM |
Nussbaum Ran | Director | May 09, 2017 | Buy | $69.11 | 9,832 | 679,474 | 3,520 | May 11, 2017, 02:02 PM |
JENKINSON PAUL L | Chief Financial Officer | May 10, 2017 | Buy | $72.59 | 3,000 | 217,770 | 3,000 | May 10, 2017, 03:12 PM |
JENKINSON PAUL L | Chief Financial Officer | May 10, 2017 | Buy | $72.57 | 450 | 32,656 | 7,480 | May 10, 2017, 03:12 PM |
Ruchefsky Steven B | Director | May 09, 2017 | Buy | $69.50 | 1,400 | 97,300 | 225,426 | May 10, 2017, 12:52 PM |
BONDERMAN DAVID | Director | May 09, 2017 | Buy | $68.94 | 50,000 | 3,446,997 | 2,408,084 | May 09, 2017, 06:29 PM |
Belldegrun Arie | Chairman, President and CEO | May 09, 2017 | Buy | $68.57 | 17,000 | 1,165,690 | 85,507 | May 09, 2017, 03:37 PM |
Kim Helen Susan | EVP, Business Development | May 01, 2017 | Option Exercise | $53.90 | 2,400 | 129,360 | 21,064 | May 03, 2017, 06:08 PM |
Kim Helen Susan | EVP, Business Development | May 01, 2017 | Sale | $82.12 | 2,400 | 197,088 | 18,664 | May 03, 2017, 06:08 PM |
Chang David D | EVP, R&D, Chief Medical Off. | May 01, 2017 | Option Exercise | $6.89 | 20,000 | 137,800 | 70,165 | May 03, 2017, 06:06 PM |
Chang David D | EVP, R&D, Chief Medical Off. | May 01, 2017 | Sale | $82.09 | 20,000 | 1,641,744 | 56,370 | May 03, 2017, 06:06 PM |
CHAMPSI FARAH | Director | Apr 28, 2017 | Sale | $82.59 | 2,617 | 216,138 | 4,962 | May 01, 2017, 06:52 PM |
CHAMPSI FARAH | Director | Apr 27, 2017 | Sale | $82.77 | 16,551 | 1,369,926 | 7,579 | May 01, 2017, 06:52 PM |
BUTITTA CYNTHIA M | Chief Operating Officer | Apr 25, 2017 | Option Exercise | $1.35 | 15,000 | 20,250 | 132,795 | Apr 27, 2017, 06:49 PM |
BUTITTA CYNTHIA M | Chief Operating Officer | Apr 25, 2017 | Sale | $81.85 | 15,000 | 1,227,690 | 127,082 | Apr 27, 2017, 06:49 PM |
CHAMPSI FARAH | Director | Apr 26, 2017 | Sale | $82.72 | 51,312 | 4,244,597 | 24,330 | Apr 26, 2017, 05:38 PM |
CHAMPSI FARAH | Director | Apr 25, 2017 | Sale | $82.80 | 46,783 | 3,873,585 | 90,758 | Apr 26, 2017, 05:38 PM |
CHAMPSI FARAH | Director | Apr 24, 2017 | Sale | $82.34 | 25,818 | 2,125,854 | 122,225 | Apr 26, 2017, 05:38 PM |
CHAMPSI FARAH | Director | Apr 17, 2017 | Sale | $82.48 | 43,101 | 3,555,029 | 148,143 | Apr 17, 2017, 09:24 PM |
CHAMPSI FARAH | Director | Apr 13, 2017 | Sale | $82.39 | 72,275 | 5,954,737 | 191,144 | Apr 17, 2017, 09:24 PM |
BUTITTA CYNTHIA M | Chief Operating Officer | Apr 03, 2017 | Option Exercise | $1.35 | 5,000 | 6,750 | 122,795 | Apr 04, 2017, 04:15 PM |
BUTITTA CYNTHIA M | Chief Operating Officer | Apr 03, 2017 | Sale | $81.96 | 5,000 | 409,798 | 120,995 | Apr 04, 2017, 04:15 PM |
BUTITTA CYNTHIA M | Chief Operating Officer | Mar 27, 2017 | Option Exercise | $1.35 | 10,000 | 13,500 | 127,795 | Mar 28, 2017, 07:57 PM |
BUTITTA CYNTHIA M | Chief Operating Officer | Mar 27, 2017 | Sale | $77.67 | 10,000 | 776,746 | 127,495 | Mar 28, 2017, 07:57 PM |
BUTITTA CYNTHIA M | Chief Operating Officer | Mar 09, 2017 | Option Exercise | $1.35 | 21,118 | 28,509 | 138,913 | Mar 10, 2017, 05:25 PM |
BUTITTA CYNTHIA M | Chief Operating Officer | Mar 09, 2017 | Sale | $80.78 | 21,118 | 1,705,929 | 126,786 | Mar 10, 2017, 05:25 PM |
Wiezorek Jeffrey | SVP Clinical Development | Mar 01, 2017 | Option Exercise | $6.89 | 18,000 | 124,020 | 39,071 | Mar 02, 2017, 06:09 AM |
Wiezorek Jeffrey | SVP Clinical Development | Mar 01, 2017 | Sale | $75.01 | 18,000 | 1,350,144 | 38,997 | Mar 02, 2017, 06:09 AM |
Chang David D | EVP, R&D, Chief Medical Off. | Mar 01, 2017 | Option Exercise | $6.89 | 60,000 | 413,400 | 110,165 | Mar 02, 2017, 06:08 AM |
Chang David D | EVP, R&D, Chief Medical Off. | Mar 01, 2017 | Sale | $79.16 | 60,000 | 4,749,441 | 54,900 | Mar 02, 2017, 06:08 AM |
DOUMANI ROY | Director | Mar 01, 2017 | Option Exercise | $1.35 | 50,000 | 67,500 | 75,065 | Mar 02, 2017, 06:06 AM |
DOUMANI ROY | Director | Mar 01, 2017 | Sale | $76.76 | 2,800 | 214,942 | 25,065 | Mar 02, 2017, 06:06 AM |
DOUMANI ROY | Director | Mar 01, 2017 | Sale | $74.05 | 16,000 | 1,184,873 | 121,017 | Mar 02, 2017, 06:06 AM |
Kim Helen Susan | EVP, Business Development | Feb 28, 2017 | Option Exercise | $52.27 | 47,900 | 2,503,756 | 66,564 | Mar 02, 2017, 06:05 AM |
Kim Helen Susan | EVP, Business Development | Mar 01, 2017 | Option Exercise | $53.90 | 2,400 | 129,360 | 21,064 | Mar 02, 2017, 06:05 AM |
Kim Helen Susan | EVP, Business Development | Mar 01, 2017 | Sale | $75.43 | 2,400 | 181,039 | 20,864 | Mar 02, 2017, 06:05 AM |
Kim Helen Susan | EVP, Business Development | Feb 28, 2017 | Sale | $67.40 | 47,900 | 3,228,372 | 64,164 | Mar 02, 2017, 06:05 AM |
BUTITTA CYNTHIA M | Chief Operating Officer | Feb 27, 2017 | Option Exercise | $1.35 | 10,000 | 13,500 | 127,795 | Mar 01, 2017, 09:59 PM |
BUTITTA CYNTHIA M | Chief Operating Officer | Mar 01, 2017 | Option Exercise | $1.35 | 28,882 | 38,991 | 146,677 | Mar 01, 2017, 09:59 PM |
BUTITTA CYNTHIA M | Chief Operating Officer | Feb 27, 2017 | Sale | $54.42 | 10,000 | 544,178 | 123,395 | Mar 01, 2017, 09:59 PM |
BUTITTA CYNTHIA M | Chief Operating Officer | Mar 01, 2017 | Sale | $80.05 | 28,882 | 2,312,004 | 117,795 | Mar 01, 2017, 09:59 PM |
Wiezorek Jeffrey | SVP Clinical Development | Feb 01, 2017 | Option Exercise | $6.89 | 1,500 | 10,335 | 22,195 | Feb 06, 2017, 04:36 PM |
Wiezorek Jeffrey | SVP Clinical Development | Feb 01, 2017 | Sale | $51.21 | 1,500 | 76,820 | 20,695 | Feb 06, 2017, 04:36 PM |
BUTITTA CYNTHIA M | Chief Operating Officer | Jan 31, 2017 | Option Exercise | $1.35 | 10,000 | 13,500 | 127,795 | Feb 01, 2017, 07:09 PM |
BUTITTA CYNTHIA M | Chief Operating Officer | Jan 31, 2017 | Sale | $50.56 | 10,000 | 505,562 | 117,795 | Feb 01, 2017, 07:09 PM |
Wiezorek Jeffrey | SVP Clinical Development | Jan 06, 2017 | Option Exercise | $6.89 | 1,500 | 10,335 | 22,195 | Jan 10, 2017, 05:04 PM |
Wiezorek Jeffrey | SVP Clinical Development | Jan 06, 2017 | Sale | $50.00 | 1,500 | 75,000 | 20,695 | Jan 10, 2017, 05:04 PM |
BUTITTA CYNTHIA M | Chief Operating Officer | Jan 06, 2017 | Option Exercise | $1.35 | 10,000 | 13,500 | 127,795 | Jan 10, 2017, 05:03 PM |
BUTITTA CYNTHIA M | Chief Operating Officer | Jan 06, 2017 | Sale | $50.13 | 10,000 | 501,289 | 117,795 | Jan 10, 2017, 05:03 PM |
Wiezorek Jeffrey | SVP Clinical Development | Dec 20, 2016 | Sale | $50.86 | 716 | 36,416 | 15,095 | Dec 22, 2016, 04:53 PM |
Tomasello Shawn | Chief Commercial Officer | Dec 20, 2016 | Sale | $50.86 | 4,901 | 249,265 | 49,635 | Dec 22, 2016, 04:52 PM |
Kim Helen Susan | EVP, Business Development | Dec 20, 2016 | Sale | $50.86 | 936 | 47,605 | 8,064 | Dec 22, 2016, 04:51 PM |
Chang David D | EVP, R&D, Chief Medical Off. | Dec 20, 2016 | Sale | $50.86 | 1,788 | 90,938 | 25,123 | Dec 22, 2016, 04:50 PM |
BUTITTA CYNTHIA M | Chief Operating Officer | Dec 20, 2016 | Sale | $50.86 | 2,482 | 126,235 | 92,995 | Dec 22, 2016, 04:48 PM |
Belldegrun Arie | Chairman, President and CEO | Dec 20, 2016 | Sale | $50.86 | 3,493 | 177,654 | 24,707 | Dec 22, 2016, 04:47 PM |
Wiezorek Jeffrey | SVP Clinical Development | Dec 01, 2016 | Option Exercise | $6.89 | 1,500 | 10,335 | 17,311 | Dec 05, 2016, 07:03 PM |
Wiezorek Jeffrey | SVP Clinical Development | Dec 01, 2016 | Sale | $50.76 | 1,500 | 76,134 | 16,018 | Dec 05, 2016, 07:03 PM |
BUTITTA CYNTHIA M | Chief Operating Officer | Nov 25, 2016 | Option Exercise | $1.35 | 10,000 | 13,500 | 105,477 | Nov 29, 2016, 05:02 PM |
BUTITTA CYNTHIA M | Chief Operating Officer | Nov 25, 2016 | Sale | $50.40 | 10,000 | 504,015 | 95,777 | Nov 29, 2016, 05:02 PM |
BUTITTA CYNTHIA M | Chief Operating Officer | Nov 10, 2016 | Option Exercise | $1.35 | 10,000 | 13,500 | 105,477 | Nov 14, 2016, 06:57 PM |
BUTITTA CYNTHIA M | Chief Operating Officer | Nov 10, 2016 | Sale | $50.65 | 10,000 | 506,466 | 95,887 | Nov 14, 2016, 06:57 PM |
Wiezorek Jeffrey | SVP Clinical Development | Nov 10, 2016 | Option Exercise | $6.89 | 1,500 | 10,335 | 17,311 | Nov 14, 2016, 06:55 PM |
Wiezorek Jeffrey | SVP Clinical Development | Nov 10, 2016 | Sale | $50.18 | 1,500 | 75,270 | 15,811 | Nov 14, 2016, 06:55 PM |
Wiezorek Jeffrey | SVP Clinical Development | Oct 03, 2016 | Option Exercise | $6.89 | 1,500 | 10,335 | 17,311 | Oct 05, 2016, 07:44 PM |
Wiezorek Jeffrey | SVP Clinical Development | Oct 03, 2016 | Sale | $54.81 | 1,500 | 82,214 | 15,981 | Oct 05, 2016, 07:44 PM |
BUTITTA CYNTHIA M | Chief Operating Officer | Sep 26, 2016 | Option Exercise | $1.35 | 10,000 | 13,500 | 105,477 | Sep 28, 2016, 05:03 PM |
BUTITTA CYNTHIA M | Chief Operating Officer | Sep 26, 2016 | Sale | $54.13 | 10,000 | 541,300 | 95,477 | Sep 28, 2016, 05:03 PM |
Wiezorek Jeffrey | SVP Clinical Development | Sep 01, 2016 | Option Exercise | $6.89 | 1,500 | 10,335 | 17,311 | Sep 02, 2016, 06:34 PM |
Wiezorek Jeffrey | SVP Clinical Development | Sep 01, 2016 | Sale | $58.24 | 1,500 | 87,362 | 16,073 | Sep 02, 2016, 06:34 PM |
BUTITTA CYNTHIA M | Chief Operating Officer | Aug 25, 2016 | Option Exercise | $1.35 | 10,000 | 13,500 | 105,477 | Aug 26, 2016, 06:38 PM |
BUTITTA CYNTHIA M | Chief Operating Officer | Aug 25, 2016 | Sale | $58.28 | 10,000 | 582,775 | 97,977 | Aug 26, 2016, 06:38 PM |
Kim Helen Susan | EVP, Business Development | Aug 15, 2016 | Option Exercise | $51.43 | 2,400 | 123,432 | 11,400 | Aug 16, 2016, 08:16 PM |
Kim Helen Susan | EVP, Business Development | Aug 12, 2016 | Option Exercise | $51.43 | 33,500 | 1,722,905 | 42,500 | Aug 16, 2016, 08:16 PM |
Kim Helen Susan | EVP, Business Development | Aug 12, 2016 | Sale | $60.08 | 33,500 | 2,012,596 | 9,000 | Aug 16, 2016, 08:16 PM |
Kim Helen Susan | EVP, Business Development | Aug 15, 2016 | Sale | $63.01 | 2,400 | 151,229 | 9,000 | Aug 16, 2016, 08:16 PM |
Wiezorek Jeffrey | SVP Clinical Development | Aug 01, 2016 | Option Exercise | $6.89 | 1,500 | 10,335 | 16,367 | Aug 02, 2016, 06:51 PM |
Wiezorek Jeffrey | SVP Clinical Development | Aug 01, 2016 | Sale | $56.90 | 1,500 | 85,343 | 15,476 | Aug 02, 2016, 06:51 PM |
BUTITTA CYNTHIA M | Chief Operating Officer | Jul 25, 2016 | Option Exercise | $1.35 | 10,000 | 13,500 | 105,401 | Jul 26, 2016, 07:03 PM |
BUTITTA CYNTHIA M | Chief Operating Officer | Jul 25, 2016 | Sale | $50.94 | 10,000 | 509,350 | 95,401 | Jul 26, 2016, 07:03 PM |
Wiezorek Jeffrey | SVP Clinical Development | Jul 01, 2016 | Option Exercise | $6.89 | 1,500 | 10,335 | 16,367 | Jul 05, 2016, 06:27 PM |
Wiezorek Jeffrey | SVP Clinical Development | Jul 01, 2016 | Sale | $50.00 | 1,500 | 75,007 | 14,867 | Jul 05, 2016, 06:27 PM |
BUTITTA CYNTHIA M | Chief Operating Officer | Jun 27, 2016 | Option Exercise | $1.35 | 10,000 | 13,500 | 105,401 | Jun 27, 2016, 07:08 PM |
BUTITTA CYNTHIA M | Chief Operating Officer | Jun 23, 2016 | Option Exercise | $1.35 | 10,000 | 13,500 | 105,401 | Jun 27, 2016, 07:08 PM |
BUTITTA CYNTHIA M | Chief Operating Officer | Jun 27, 2016 | Sale | $50.15 | 10,000 | 501,484 | 95,401 | Jun 27, 2016, 07:08 PM |
BUTITTA CYNTHIA M | Chief Operating Officer | Jun 23, 2016 | Sale | $51.28 | 10,000 | 512,754 | 95,401 | Jun 27, 2016, 07:08 PM |
DOUMANI ROY | Director | Jun 06, 2016 | Sale | $58.38 | 4,000 | 233,516 | 27,865 | Jun 08, 2016, 07:27 PM |
DOUMANI ROY | Director | Jun 06, 2016 | Sale | $57.91 | 10,000 | 579,065 | 136,017 | Jun 08, 2016, 07:27 PM |
Wiezorek Jeffrey | SVP Clinical Development | Jun 01, 2016 | Option Exercise | $6.89 | 1,500 | 10,335 | 16,367 | Jun 02, 2016, 05:15 PM |
Wiezorek Jeffrey | SVP Clinical Development | May 31, 2016 | Option Exercise | $6.89 | 1,500 | 10,335 | 16,367 | Jun 02, 2016, 05:15 PM |
Wiezorek Jeffrey | SVP Clinical Development | Jun 01, 2016 | Sale | $51.30 | 1,500 | 76,949 | 15,042 | Jun 02, 2016, 05:15 PM |
Wiezorek Jeffrey | SVP Clinical Development | May 31, 2016 | Sale | $50.00 | 1,500 | 75,000 | 14,867 | Jun 02, 2016, 05:15 PM |
BUTITTA CYNTHIA M | COO and CFO | Apr 04, 2016 | Option Exercise | $1.35 | 10,000 | 13,500 | 105,401 | Apr 06, 2016, 07:06 PM |
BUTITTA CYNTHIA M | COO and CFO | Apr 04, 2016 | Sale | $50.00 | 10,000 | 500,000 | 95,401 | Apr 06, 2016, 07:06 PM |
Wiezorek Jeffrey | SVP Clinical Development | Mar 15, 2016 | Option Exercise | $6.89 | 9,000 | 62,010 | 23,867 | Mar 17, 2016, 09:15 PM |
Wiezorek Jeffrey | SVP Clinical Development | Mar 15, 2016 | Sale | $44.88 | 9,000 | 403,943 | 17,125 | Mar 17, 2016, 09:15 PM |
Sproule Rizwana F | VP Regulatory Affairs | Mar 15, 2016 | Option Exercise | $1.35 | 8,500 | 11,475 | 18,711 | Mar 17, 2016, 09:15 PM |
Sproule Rizwana F | VP Regulatory Affairs | Mar 15, 2016 | Sale | $45.27 | 8,500 | 384,791 | 10,899 | Mar 17, 2016, 09:15 PM |
Roberts Margo R | Chief Scientific Officer | Mar 15, 2016 | Option Exercise | $2.63 | 8,506 | 22,352 | 19,161 | Mar 17, 2016, 09:14 PM |
Roberts Margo R | Chief Scientific Officer | Mar 15, 2016 | Sale | $45.23 | 8,506 | 384,766 | 11,346 | Mar 17, 2016, 09:14 PM |
Roberts Margo R | Chief Scientific Officer | Feb 17, 2016 | Option Exercise | $2.40 | 9,632 | 23,156 | 18,730 | Mar 17, 2016, 09:13 PM |
BUTITTA CYNTHIA M | COO and CFO | Mar 01, 2016 | Option Exercise | $1.35 | 10,000 | 13,500 | 105,401 | Mar 03, 2016, 07:13 PM |
BUTITTA CYNTHIA M | COO and CFO | Mar 01, 2016 | Sale | $50.03 | 10,000 | 500,300 | 95,401 | Mar 03, 2016, 07:13 PM |
Roberts Margo R | Chief Scientific Officer | Feb 17, 2016 | Option Exercise | $0.70 | 9,632 | 6,742 | 18,730 | Feb 19, 2016, 04:14 PM |
Roberts Margo R | Chief Scientific Officer | Feb 17, 2016 | Sale | $45.06 | 9,632 | 434,018 | 9,198 | Feb 19, 2016, 04:14 PM |
Sproule Rizwana F | VP Regulatory Affairs | Feb 17, 2016 | Option Exercise | $1.35 | 9,567 | 12,915 | 18,308 | Feb 19, 2016, 04:13 PM |
Sproule Rizwana F | VP Regulatory Affairs | Feb 17, 2016 | Sale | $45.08 | 9,567 | 431,279 | 8,841 | Feb 19, 2016, 04:13 PM |
Wiezorek Jeffrey | SVP Clinical Development | Feb 16, 2016 | Option Exercise | $6.89 | 9,000 | 62,010 | 22,742 | Feb 18, 2016, 08:34 PM |
Wiezorek Jeffrey | SVP Clinical Development | Feb 16, 2016 | Sale | $44.07 | 9,000 | 396,652 | 15,130 | Feb 18, 2016, 08:34 PM |
Roberts Margo R | Chief Scientific Officer | Feb 12, 2016 | Option Exercise | $0.70 | 18,750 | 13,125 | 27,848 | Feb 16, 2016, 07:05 PM |
Roberts Margo R | Chief Scientific Officer | Feb 12, 2016 | Sale | $64.16 | 18,750 | 1,202,964 | 9,098 | Feb 16, 2016, 07:05 PM |
BUTITTA CYNTHIA M | COO and CFO | Feb 02, 2016 | Option Exercise | $1.35 | 1,900 | 2,565 | 95,907 | Feb 04, 2016, 09:06 PM |
BUTITTA CYNTHIA M | COO and CFO | Feb 02, 2016 | Sale | $50.13 | 1,900 | 95,247 | 94,007 | Feb 04, 2016, 09:06 PM |
Better Marc | VP, Product Sciences | Feb 01, 2016 | Option Exercise | $0.38 | 9,000 | 3,420 | 16,688 | Feb 03, 2016, 07:04 PM |
Better Marc | VP, Product Sciences | Feb 01, 2016 | Sale | $47.34 | 9,000 | 426,036 | 14,189 | Feb 03, 2016, 07:04 PM |
BUTITTA CYNTHIA M | COO and CFO | Jan 27, 2016 | Option Exercise | $1.35 | 8,100 | 10,935 | 102,107 | Jan 29, 2016, 06:15 PM |
BUTITTA CYNTHIA M | COO and CFO | Jan 27, 2016 | Sale | $51.62 | 8,100 | 418,128 | 99,607 | Jan 29, 2016, 06:15 PM |
Wiezorek Jeffrey | SVP Clinical Development | Jan 15, 2016 | Option Exercise | $6.89 | 9,000 | 62,010 | 22,742 | Jan 19, 2016, 08:24 PM |
Wiezorek Jeffrey | SVP Clinical Development | Jan 15, 2016 | Sale | $55.26 | 9,000 | 497,379 | 22,368 | Jan 19, 2016, 08:24 PM |
Sproule Rizwana F | VP Regulatory Affairs | Jan 19, 2016 | Option Exercise | $1.35 | 2,767 | 3,735 | 11,508 | Jan 19, 2016, 08:23 PM |
Sproule Rizwana F | VP Regulatory Affairs | Jan 15, 2016 | Option Exercise | $1.35 | 6,800 | 9,180 | 15,541 | Jan 19, 2016, 08:23 PM |
Sproule Rizwana F | VP Regulatory Affairs | Jan 19, 2016 | Sale | $56.10 | 2,767 | 155,242 | 11,011 | Jan 19, 2016, 08:23 PM |
Sproule Rizwana F | VP Regulatory Affairs | Jan 15, 2016 | Sale | $55.23 | 6,800 | 375,589 | 15,270 | Jan 19, 2016, 08:23 PM |
Roberts Margo R | Chief Scientific Officer | Jan 15, 2016 | Option Exercise | $2.41 | 6,145 | 14,815 | 15,243 | Jan 19, 2016, 08:22 PM |
Roberts Margo R | Chief Scientific Officer | Jan 15, 2016 | Sale | $55.22 | 6,145 | 339,323 | 14,979 | Jan 19, 2016, 08:22 PM |
Better Marc | VP, Product Sciences | Jan 04, 2016 | Option Exercise | $0.38 | 9,000 | 3,420 | 16,688 | Jan 05, 2016, 07:45 PM |
Better Marc | VP, Product Sciences | Jan 04, 2016 | Sale | $61.53 | 9,000 | 553,788 | 14,517 | Jan 05, 2016, 07:45 PM |
BUTITTA CYNTHIA M | COO and CFO | Dec 28, 2015 | Option Exercise | $1.35 | 10,000 | 13,500 | 104,007 | Dec 29, 2015, 07:17 PM |
BUTITTA CYNTHIA M | COO and CFO | Dec 28, 2015 | Sale | $61.56 | 10,000 | 615,599 | 96,717 | Dec 29, 2015, 07:17 PM |
Wiezorek Jeffrey | SVP Clinical Development | Dec 15, 2015 | Option Exercise | $6.89 | 9,000 | 62,010 | 15,342 | Dec 17, 2015, 07:33 PM |
Wiezorek Jeffrey | SVP Clinical Development | Dec 15, 2015 | Sale | $63.78 | 9,000 | 573,989 | 12,606 | Dec 17, 2015, 07:33 PM |
Roberts Margo R | Chief Scientific Officer | Dec 15, 2015 | Option Exercise | $2.41 | 6,145 | 14,815 | 8,343 | Dec 17, 2015, 07:33 PM |
Roberts Margo R | Chief Scientific Officer | Dec 15, 2015 | Sale | $63.76 | 6,145 | 391,815 | 5,743 | Dec 17, 2015, 07:33 PM |
Sproule Rizwana F | VP Regulatory Affairs | Dec 15, 2015 | Option Exercise | $1.35 | 9,567 | 12,915 | 12,508 | Dec 17, 2015, 07:32 PM |
Sproule Rizwana F | VP Regulatory Affairs | Dec 15, 2015 | Sale | $63.76 | 9,567 | 609,994 | 9,135 | Dec 17, 2015, 07:32 PM |
Better Marc | VP, Product Sciences | Dec 01, 2015 | Option Exercise | $0.38 | 9,000 | 3,420 | 10,888 | Dec 03, 2015, 06:53 PM |
Better Marc | VP, Product Sciences | Dec 01, 2015 | Sale | $76.31 | 9,000 | 686,819 | 9,983 | Dec 03, 2015, 06:53 PM |
BUTITTA CYNTHIA M | COO and CFO | Nov 27, 2015 | Option Exercise | $1.35 | 15,000 | 20,250 | 90,507 | Nov 30, 2015, 08:23 PM |
BUTITTA CYNTHIA M | COO and CFO | Nov 27, 2015 | Sale | $86.45 | 15,000 | 1,296,680 | 78,107 | Nov 30, 2015, 08:23 PM |
Roberts Margo R | Chief Scientific Officer | Nov 16, 2015 | Option Exercise | $2.41 | 6,145 | 14,815 | 8,343 | Nov 18, 2015, 07:32 PM |
Roberts Margo R | Chief Scientific Officer | Nov 16, 2015 | Sale | $78.16 | 6,145 | 480,270 | 7,343 | Nov 18, 2015, 07:32 PM |
Wiezorek Jeffrey | SVP Clinical Development | Nov 16, 2015 | Option Exercise | $6.89 | 9,000 | 62,010 | 15,342 | Nov 18, 2015, 07:31 PM |
Wiezorek Jeffrey | SVP Clinical Development | Nov 16, 2015 | Sale | $78.08 | 9,000 | 702,681 | 13,930 | Nov 18, 2015, 07:31 PM |
Sproule Rizwana F | VP Regulatory Affairs | Nov 16, 2015 | Option Exercise | $1.35 | 9,567 | 12,915 | 12,508 | Nov 18, 2015, 07:29 PM |
Sproule Rizwana F | VP Regulatory Affairs | Nov 16, 2015 | Sale | $78.13 | 9,567 | 747,507 | 11,084 | Nov 18, 2015, 07:29 PM |
BUTITTA CYNTHIA M | COO and CFO | Nov 10, 2015 | Option Exercise | $1.35 | 5,000 | 6,750 | 80,507 | Nov 12, 2015, 06:33 PM |
BUTITTA CYNTHIA M | COO and CFO | Nov 10, 2015 | Sale | $80.00 | 5,000 | 400,000 | 75,507 | Nov 12, 2015, 06:33 PM |
Chang David D | EVP, R&D, Chief Medical Off. | Nov 10, 2015 | Option Exercise | $6.89 | 30,800 | 212,212 | 37,704 | Nov 12, 2015, 06:32 PM |
Chang David D | EVP, R&D, Chief Medical Off. | Nov 10, 2015 | Sale | $80.02 | 30,800 | 2,464,616 | 6,904 | Nov 12, 2015, 06:32 PM |
Better Marc | VP, Product Sciences | Nov 02, 2015 | Option Exercise | $0.38 | 9,000 | 3,420 | 10,888 | Nov 04, 2015, 07:06 PM |
Better Marc | VP, Product Sciences | Nov 02, 2015 | Sale | $71.07 | 9,000 | 639,652 | 10,298 | Nov 04, 2015, 07:06 PM |
Chang David D | EVP, R&D, Chief Medical Off. | Nov 02, 2015 | Option Exercise | $6.89 | 7,700 | 53,053 | 14,604 | Nov 04, 2015, 07:05 PM |
Chang David D | EVP, R&D, Chief Medical Off. | Nov 02, 2015 | Sale | $71.08 | 7,700 | 547,292 | 14,127 | Nov 04, 2015, 07:05 PM |
BUTITTA CYNTHIA M | COO and CFO | Oct 27, 2015 | Option Exercise | $1.35 | 10,000 | 13,500 | 85,507 | Oct 28, 2015, 07:17 PM |
BUTITTA CYNTHIA M | COO and CFO | Oct 27, 2015 | Sale | $69.91 | 10,000 | 699,120 | 80,407 | Oct 28, 2015, 07:17 PM |
Sproule Rizwana F | VP Regulatory Affairs | Oct 15, 2015 | Option Exercise | $1.35 | 9,567 | 12,915 | 12,508 | Oct 19, 2015, 07:30 PM |
Sproule Rizwana F | VP Regulatory Affairs | Oct 15, 2015 | Sale | $62.58 | 9,567 | 598,731 | 12,113 | Oct 19, 2015, 07:30 PM |
Wiezorek Jeffrey | SVP Clinical Development | Oct 15, 2015 | Option Exercise | $6.89 | 9,000 | 62,010 | 15,342 | Oct 19, 2015, 07:29 PM |
Wiezorek Jeffrey | SVP Clinical Development | Oct 15, 2015 | Sale | $62.59 | 9,000 | 563,319 | 14,891 | Oct 19, 2015, 07:29 PM |
Roberts Margo R | Chief Scientific Officer | Oct 15, 2015 | Option Exercise | $2.41 | 6,145 | 14,815 | 8,343 | Oct 19, 2015, 07:28 PM |
Roberts Margo R | Chief Scientific Officer | Oct 15, 2015 | Sale | $62.57 | 6,145 | 384,509 | 7,982 | Oct 19, 2015, 07:28 PM |
Chang David D | EVP, R&D, Chief Medical Off. | Oct 01, 2015 | Option Exercise | $6.89 | 7,700 | 53,053 | 14,604 | Oct 02, 2015, 07:19 PM |
Chang David D | EVP, R&D, Chief Medical Off. | Oct 01, 2015 | Sale | $55.11 | 7,700 | 424,347 | 6,904 | Oct 02, 2015, 07:19 PM |
Better Marc | VP, Product Sciences | Oct 01, 2015 | Option Exercise | $0.38 | 9,000 | 3,420 | 10,888 | Oct 02, 2015, 07:18 PM |
Better Marc | VP, Product Sciences | Oct 01, 2015 | Sale | $54.81 | 9,000 | 493,326 | 9,758 | Oct 02, 2015, 07:18 PM |
BUTITTA CYNTHIA M | COO and CFO | Sep 28, 2015 | Option Exercise | $1.35 | 10,000 | 13,500 | 85,507 | Sep 30, 2015, 07:01 PM |
BUTITTA CYNTHIA M | COO and CFO | Sep 28, 2015 | Sale | $55.87 | 10,000 | 558,672 | 82,707 | Sep 30, 2015, 07:01 PM |
Wiezorek Jeffrey | VP Clinical Development | Sep 15, 2015 | Option Exercise | $6.89 | 9,000 | 62,010 | 15,342 | Sep 17, 2015, 08:01 PM |
Wiezorek Jeffrey | VP Clinical Development | Sep 15, 2015 | Sale | $64.34 | 9,000 | 579,018 | 10,782 | Sep 17, 2015, 08:01 PM |
Sproule Rizwana F | VP Regulatory Affairs | Sep 15, 2015 | Option Exercise | $1.35 | 9,567 | 12,915 | 12,508 | Sep 17, 2015, 08:00 PM |
Sproule Rizwana F | VP Regulatory Affairs | Sep 15, 2015 | Sale | $64.36 | 9,567 | 615,733 | 8,234 | Sep 17, 2015, 08:00 PM |
Roberts Margo R | Chief Scientific Officer | Sep 15, 2015 | Option Exercise | $2.41 | 6,145 | 14,815 | 8,343 | Sep 17, 2015, 07:59 PM |
Roberts Margo R | Chief Scientific Officer | Sep 15, 2015 | Sale | $64.33 | 6,145 | 395,320 | 5,379 | Sep 17, 2015, 07:59 PM |
Chang David D | EVP, R&D, Chief Medical Off. | Sep 08, 2015 | Option Exercise | $6.89 | 7,384 | 50,876 | 14,288 | Sep 08, 2015, 07:14 PM |
Chang David D | EVP, R&D, Chief Medical Off. | Sep 03, 2015 | Option Exercise | $6.89 | 316 | 2,177 | 7,220 | Sep 08, 2015, 07:14 PM |
Chang David D | EVP, R&D, Chief Medical Off. | Sep 08, 2015 | Sale | $55.00 | 7,384 | 406,120 | 6,904 | Sep 08, 2015, 07:14 PM |
Chang David D | EVP, R&D, Chief Medical Off. | Sep 03, 2015 | Sale | $55.00 | 316 | 17,380 | 6,904 | Sep 08, 2015, 07:14 PM |
Better Marc | VP, Product Sciences | Sep 01, 2015 | Option Exercise | $0.38 | 9,000 | 3,420 | 10,888 | Sep 03, 2015, 07:07 PM |
Better Marc | VP, Product Sciences | Sep 01, 2015 | Sale | $51.81 | 9,000 | 466,292 | 5,869 | Sep 03, 2015, 07:07 PM |
BUTITTA CYNTHIA M | COO and CFO | Aug 27, 2015 | Option Exercise | $1.35 | 10,000 | 13,500 | 85,507 | Aug 28, 2015, 07:07 PM |
BUTITTA CYNTHIA M | COO and CFO | Aug 27, 2015 | Sale | $53.62 | 10,000 | 536,156 | 83,407 | Aug 28, 2015, 07:07 PM |
Wiezorek Jeffrey | VP Clinical Development | Aug 17, 2015 | Option Exercise | $6.89 | 9,000 | 62,010 | 14,218 | Aug 19, 2015, 08:04 PM |
Wiezorek Jeffrey | VP Clinical Development | Aug 17, 2015 | Sale | $60.87 | 9,000 | 547,820 | 10,807 | Aug 19, 2015, 08:04 PM |
Sproule Rizwana F | VP Regulatory Affairs | Aug 17, 2015 | Option Exercise | $1.35 | 9,567 | 12,915 | 11,262 | Aug 19, 2015, 08:03 PM |
Sproule Rizwana F | VP Regulatory Affairs | Aug 17, 2015 | Sale | $60.88 | 9,567 | 582,407 | 8,482 | Aug 19, 2015, 08:03 PM |
Roberts Margo R | Chief Scientific Officer | Aug 17, 2015 | Option Exercise | $2.41 | 6,145 | 14,815 | 7,144 | Aug 19, 2015, 08:01 PM |
Roberts Margo R | Chief Scientific Officer | Aug 17, 2015 | Sale | $60.90 | 6,145 | 374,236 | 5,588 | Aug 19, 2015, 08:01 PM |
Better Marc | VP, Product Sciences | Aug 03, 2015 | Option Exercise | $0.38 | 9,000 | 3,420 | 10,017 | Aug 04, 2015, 07:30 PM |
Better Marc | VP, Product Sciences | Aug 03, 2015 | Sale | $72.14 | 9,000 | 649,246 | 6,348 | Aug 04, 2015, 07:30 PM |
Chang David D | EVP, R&D, Chief Medical Off. | Aug 03, 2015 | Option Exercise | $6.89 | 7,700 | 53,053 | 13,700 | Aug 04, 2015, 07:29 PM |
Chang David D | EVP, R&D, Chief Medical Off. | Aug 03, 2015 | Sale | $72.11 | 7,700 | 555,242 | 10,800 | Aug 04, 2015, 07:29 PM |
BUTITTA CYNTHIA M | COO and CFO | Jul 27, 2015 | Option Exercise | $1.35 | 10,000 | 13,500 | 84,566 | Jul 28, 2015, 07:03 PM |
BUTITTA CYNTHIA M | COO and CFO | Jul 27, 2015 | Sale | $68.48 | 10,000 | 684,818 | 78,804 | Jul 28, 2015, 07:03 PM |
Roberts Margo R | Chief Scientific Officer | Jul 15, 2015 | Option Exercise | $10.66 | 22,167 | 236,251 | 23,166 | Jul 23, 2015, 02:29 PM |
Roberts Margo R | Chief Scientific Officer | Jul 15, 2015 | Sale | $71.89 | 22,167 | 1,593,674 | 21,735 | Jul 23, 2015, 02:29 PM |
Wiezorek Jeffrey | VP Clinical Development | Jul 15, 2015 | Option Exercise | $6.89 | 9,000 | 62,010 | 14,218 | Jul 20, 2015, 09:03 PM |
Wiezorek Jeffrey | VP Clinical Development | Jul 15, 2015 | Sale | $71.92 | 9,000 | 647,257 | 13,812 | Jul 20, 2015, 09:03 PM |
Sproule Rizwana F | VP Regulatory Affairs | Jul 15, 2015 | Option Exercise | $1.35 | 9,567 | 12,915 | 11,262 | Jul 20, 2015, 09:02 PM |
Sproule Rizwana F | VP Regulatory Affairs | Jul 15, 2015 | Sale | $71.90 | 9,567 | 687,828 | 10,296 | Jul 20, 2015, 09:02 PM |
Better Marc | VP, Product Sciences | Jul 01, 2015 | Option Exercise | $0.38 | 9,000 | 3,420 | 10,017 | Jul 02, 2015, 08:36 PM |
Better Marc | VP, Product Sciences | Jul 01, 2015 | Sale | $61.90 | 9,000 | 557,075 | 6,708 | Jul 02, 2015, 08:36 PM |
Chang David D | EVP, R&D, Chief Medical Off. | Jul 01, 2015 | Option Exercise | $6.89 | 7,700 | 53,053 | 13,700 | Jul 02, 2015, 08:35 PM |
Chang David D | EVP, R&D, Chief Medical Off. | Jul 01, 2015 | Sale | $61.92 | 7,700 | 476,781 | 10,306 | Jul 02, 2015, 08:35 PM |
CHAMPSI FARAH | Director | Jun 30, 2015 | Sale | $62.35 | 664,102 | 41,403,802 | 2,234,261 | Jul 02, 2015, 07:44 PM |
BUTITTA CYNTHIA M | COO and CFO | Jun 29, 2015 | Option Exercise | $1.35 | 10,000 | 13,500 | 84,566 | Jul 01, 2015, 07:15 PM |
BUTITTA CYNTHIA M | COO and CFO | Jun 29, 2015 | Sale | $59.65 | 10,000 | 596,542 | 80,766 | Jul 01, 2015, 07:15 PM |
Wiezorek Jeffrey | VP Clinical Development | Jun 15, 2015 | Option Exercise | $6.89 | 9,000 | 62,010 | 14,218 | Jun 17, 2015, 07:19 PM |
Wiezorek Jeffrey | VP Clinical Development | Jun 25, 2014 | Buy | $17.00 | 4,000 | 68,000 | 5,218 | Jun 17, 2015, 07:19 PM |
Wiezorek Jeffrey | VP Clinical Development | Jun 15, 2015 | Sale | $57.00 | 9,000 | 513,031 | 11,608 | Jun 17, 2015, 07:19 PM |
Chang David D | EVP, R&D, Chief Medical Off. | Jun 15, 2015 | Option Exercise | $6.89 | 7,700 | 53,053 | 13,700 | Jun 17, 2015, 07:17 PM |
Chang David D | EVP, R&D, Chief Medical Off. | Jun 25, 2014 | Buy | $17.00 | 4,000 | 68,000 | 6,000 | Jun 17, 2015, 07:17 PM |
Chang David D | EVP, R&D, Chief Medical Off. | Jun 15, 2015 | Sale | $56.98 | 7,700 | 438,749 | 11,267 | Jun 17, 2015, 07:17 PM |
Sproule Rizwana F | VP Regulatory Affairs | Jun 15, 2015 | Option Exercise | $1.35 | 9,567 | 12,915 | 11,262 | Jun 17, 2015, 07:16 PM |
Sproule Rizwana F | VP Regulatory Affairs | Jun 15, 2015 | Sale | $56.98 | 9,567 | 545,168 | 8,371 | Jun 17, 2015, 07:16 PM |
Roberts Margo R | Chief Scientific Officer | Jun 15, 2015 | Option Exercise | $0.70 | 8,625 | 6,037 | 9,624 | Jun 17, 2015, 07:15 PM |
Roberts Margo R | Chief Scientific Officer | Jun 15, 2015 | Sale | $56.99 | 8,625 | 491,497 | 7,047 | Jun 17, 2015, 07:15 PM |
Nussbaum Ran | Director | Jun 02, 2015 | Sale | $55.36 | 224,674 | 12,437,229 | 24,070 | Jun 03, 2015, 07:40 PM |
Nussbaum Ran | Director | Jun 01, 2015 | Sale | $55.34 | 80,760 | 4,469,230 | 236,228 | Jun 03, 2015, 07:40 PM |
Better Marc | VP, Product Sciences | Jun 01, 2015 | Option Exercise | $0.38 | 9,000 | 3,420 | 10,017 | Jun 03, 2015, 07:38 PM |
Better Marc | VP, Product Sciences | Jun 01, 2015 | Sale | $54.60 | 9,000 | 491,421 | 5,766 | Jun 03, 2015, 07:38 PM |
BUTITTA CYNTHIA M | COO and CFO | May 27, 2015 | Option Exercise | $1.35 | 10,000 | 13,500 | 84,566 | May 29, 2015, 06:56 PM |
BUTITTA CYNTHIA M | COO and CFO | May 27, 2015 | Sale | $50.59 | 10,000 | 505,934 | 74,766 | May 29, 2015, 06:56 PM |
Roberts Margo R | Chief Scientific Officer | May 15, 2015 | Option Exercise | $0.70 | 8,625 | 6,037 | 9,624 | May 19, 2015, 08:02 PM |
Roberts Margo R | Chief Scientific Officer | May 15, 2015 | Sale | $50.17 | 8,625 | 432,709 | 5,133 | May 19, 2015, 08:02 PM |
Wiezorek Jeffrey | VP Clinical Development | May 15, 2015 | Option Exercise | $6.89 | 9,000 | 62,010 | 10,218 | May 19, 2015, 08:01 PM |
Wiezorek Jeffrey | VP Clinical Development | May 15, 2015 | Sale | $50.15 | 9,000 | 451,339 | 5,512 | May 19, 2015, 08:01 PM |
Sproule Rizwana F | VP Regulatory Affairs | May 15, 2015 | Option Exercise | $1.35 | 9,567 | 12,915 | 11,262 | May 19, 2015, 08:00 PM |
Sproule Rizwana F | VP Regulatory Affairs | May 15, 2015 | Sale | $50.16 | 9,567 | 479,867 | 6,076 | May 19, 2015, 08:00 PM |
Better Marc | VP, Product Sciences | May 01, 2015 | Option Exercise | $0.38 | 9,000 | 3,420 | 10,017 | May 05, 2015, 08:28 PM |
Better Marc | VP, Product Sciences | May 01, 2015 | Sale | $50.72 | 9,000 | 456,451 | 5,861 | May 05, 2015, 08:28 PM |
BUTITTA CYNTHIA M | COO and CFO | Apr 27, 2015 | Option Exercise | $1.35 | 10,000 | 13,500 | 74,566 | Apr 29, 2015, 09:54 PM |
BUTITTA CYNTHIA M | COO and CFO | Apr 27, 2015 | Sale | $59.76 | 10,000 | 597,624 | 64,566 | Apr 29, 2015, 05:48 PM |
Nussbaum Ran | Director | Mar 30, 2015 | Sale | $59.91 | 115,857 | 6,941,468 | 149,116 | Mar 31, 2015, 08:38 PM |
Nussbaum Ran | Director | Mar 27, 2015 | Sale | $61.24 | 77,873 | 4,769,020 | 216,064 | Mar 31, 2015, 08:38 PM |
Peacock Jonathan M | Director | Jun 25, 2014 | Option Exercise | $15.30 | 66,014 | 1,010,014 | 66,014 | Jun 27, 2014, 05:52 PM |
CHAMPSI FARAH | Director | Jun 25, 2014 | Option Exercise | $15.30 | 759,170 | 11,615,301 | 2,926,059 | Jun 27, 2014, 05:42 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
Owner | Relationship | Date | Value($) |
Peacock Jonathan M | Director | 10/03/2017 | 12,227,760 |
CLARK IAN T | Director | 10/03/2017 | 319,680 |
Kazam Joshua A | Director | 10/03/2017 | 12,609,000 |
Kazam Joshua A | Director | 10/03/2017 | 459,540 |
Humer Franz B | Director | 10/03/2017 | 832,320 |
DOUMANI ROY | Director | 10/03/2017 | 27,111,600 |
DOUMANI ROY | Director | 10/03/2017 | 4,511,700 |
CHAMPSI FARAH | Director | 10/03/2017 | 11,064,060 |
WITTE OWEN N. | Director | 10/03/2017 | 10,536,300 |
MOORE TIMOTHY L. | EVP, Technical Operations | 10/03/2017 | 706,860 |
Tomasello Shawn | Chief Commercial Officer | 10/03/2017 | 2,904,300 |
Wiezorek Jeffrey | SVP Clinical Development | 10/03/2017 | 2,641,320 |
Kim Helen Susan | EVP, Business Development | 10/03/2017 | 754,740 |
JENKINSON PAUL L | Chief Financial Officer | 10/03/2017 | 540,000 |
Chang David D | EVP, R&D, Chief Medical Off. | 10/03/2017 | 2,988,900 |
Belldegrun Arie | Chairman, President and CEO | 10/03/2017 | 575,508,420 |
Tomasello Shawn | Chief Commercial Officer | 09/25/2017 | 755,128 |
Kim Helen Susan | EVP, Business Development | 09/25/2017 | 569,715 |
MOORE TIMOTHY L. | EVP, Technical Operations | 09/25/2017 | 759,619 |
MOORE TIMOTHY L. | EVP, Technical Operations | 03/15/2017 | 625,741 |
Wiezorek Jeffrey | SVP Clinical Development | 09/25/2017 | 949,165 |
Chang David D | EVP, R&D, Chief Medical Off. | 09/25/2017 | 1,424,197 |
JENKINSON PAUL L | Chief Financial Officer | 09/25/2017 | 170,321 |
BUTITTA CYNTHIA M | Chief Operating Officer | 09/25/2017 | 759,619 |
Belldegrun Arie | Chairman, President and CEO | 09/25/2017 | 4,733,607 |
Kim Helen Susan | EVP, Business Development | 08/10/2017 | 330,369 |
Kim Helen Susan | EVP, Business Development | 08/10/2017 | 750,683 |
BUTITTA CYNTHIA M | Chief Operating Officer | 08/10/2017 | 20,250 |
BUTITTA CYNTHIA M | Chief Operating Officer | 08/10/2017 | 1,810,758 |
Kim Helen Susan | EVP, Business Development | 08/08/2017 | 4,309,251 |
Kim Helen Susan | EVP, Business Development | 08/08/2017 | 9,558,324 |
MOORE TIMOTHY L. | EVP, Technical Operations | 08/03/2017 | 269,460 |
MOORE TIMOTHY L. | EVP, Technical Operations | 08/03/2017 | 660,343 |
MOORE TIMOTHY L. | EVP, Technical Operations | 08/01/2017 | 134,730 |
MOORE TIMOTHY L. | EVP, Technical Operations | 08/01/2017 | 1,292,322 |
Kim Helen Susan | EVP, Business Development | 07/31/2017 | 1,411,437 |
Kim Helen Susan | EVP, Business Development | 07/31/2017 | 2,912,272 |
BUTITTA CYNTHIA M | Chief Operating Officer | 07/10/2017 | 20,250 |
BUTITTA CYNTHIA M | Chief Operating Officer | 07/10/2017 | 1,546,300 |
Wiezorek Jeffrey | SVP Clinical Development | 07/03/2017 | 68,900 |
Wiezorek Jeffrey | SVP Clinical Development | 07/03/2017 | 1,043,201 |
BUTITTA CYNTHIA M | Chief Operating Officer | 06/23/2017 | 6,750 |
BUTITTA CYNTHIA M | Chief Operating Officer | 06/23/2017 | 504,033 |
BUTITTA CYNTHIA M | Chief Operating Officer | 06/23/2017 | 504,033 |
WITTE OWEN N. | Director | 06/23/2017 | 225,000 |
WITTE OWEN N. | Director | 06/26/2017 | 1,257,500 |
WITTE OWEN N. | Director | 06/23/2017 | 1,250,000 |
Ruchefsky Steven B | Director | 06/14/2017 | 1,789,574 |
CHAMPSI FARAH | Director | 06/16/2017 | 480,200 |
CHAMPSI FARAH | Director | 06/14/2017 | 1,356,000 |
BUTITTA CYNTHIA M | Chief Operating Officer | 06/09/2017 | 13,500 |
BUTITTA CYNTHIA M | Chief Operating Officer | 06/09/2017 | 885,491 |
DOUMANI ROY | Director | 06/08/2017 | 422,634 |
DOUMANI ROY | Director | 06/07/2017 | 844,621 |
Kim Helen Susan | EVP, Business Development | 06/01/2017 | 123,432 |
Kim Helen Susan | EVP, Business Development | 06/01/2017 | 173,880 |
Nussbaum Ran | Director | 05/09/2017 | 679,474 |
JENKINSON PAUL L | Chief Financial Officer | 05/10/2017 | 217,770 |
JENKINSON PAUL L | Chief Financial Officer | 05/10/2017 | 32,656 |
Ruchefsky Steven B | Director | 05/09/2017 | 97,300 |
BONDERMAN DAVID | Director | 05/09/2017 | 3,446,997 |
Belldegrun Arie | Chairman, President and CEO | 05/09/2017 | 1,165,690 |
Kim Helen Susan | EVP, Business Development | 05/01/2017 | 129,360 |
Kim Helen Susan | EVP, Business Development | 05/01/2017 | 197,088 |
Chang David D | EVP, R&D, Chief Medical Off. | 05/01/2017 | 137,800 |
Chang David D | EVP, R&D, Chief Medical Off. | 05/01/2017 | 1,641,744 |
CHAMPSI FARAH | Director | 04/28/2017 | 216,138 |
CHAMPSI FARAH | Director | 04/27/2017 | 1,369,926 |
BUTITTA CYNTHIA M | Chief Operating Officer | 04/25/2017 | 20,250 |
BUTITTA CYNTHIA M | Chief Operating Officer | 04/25/2017 | 1,227,690 |
CHAMPSI FARAH | Director | 04/26/2017 | 4,244,597 |
CHAMPSI FARAH | Director | 04/25/2017 | 3,873,585 |
CHAMPSI FARAH | Director | 04/24/2017 | 2,125,854 |
CHAMPSI FARAH | Director | 04/17/2017 | 3,555,029 |
CHAMPSI FARAH | Director | 04/13/2017 | 5,954,737 |
BUTITTA CYNTHIA M | Chief Operating Officer | 04/03/2017 | 6,750 |
BUTITTA CYNTHIA M | Chief Operating Officer | 04/03/2017 | 409,798 |
BUTITTA CYNTHIA M | Chief Operating Officer | 03/27/2017 | 13,500 |
BUTITTA CYNTHIA M | Chief Operating Officer | 03/27/2017 | 776,746 |
BUTITTA CYNTHIA M | Chief Operating Officer | 03/09/2017 | 28,509 |
BUTITTA CYNTHIA M | Chief Operating Officer | 03/09/2017 | 1,705,929 |
Wiezorek Jeffrey | SVP Clinical Development | 03/01/2017 | 124,020 |
Wiezorek Jeffrey | SVP Clinical Development | 03/01/2017 | 1,350,144 |
Chang David D | EVP, R&D, Chief Medical Off. | 03/01/2017 | 413,400 |
Chang David D | EVP, R&D, Chief Medical Off. | 03/01/2017 | 4,749,441 |
DOUMANI ROY | Director | 03/01/2017 | 67,500 |
DOUMANI ROY | Director | 03/01/2017 | 214,942 |
DOUMANI ROY | Director | 03/01/2017 | 1,184,873 |
Kim Helen Susan | EVP, Business Development | 02/28/2017 | 2,503,756 |
Kim Helen Susan | EVP, Business Development | 03/01/2017 | 129,360 |
Kim Helen Susan | EVP, Business Development | 03/01/2017 | 181,039 |
Kim Helen Susan | EVP, Business Development | 02/28/2017 | 3,228,372 |
BUTITTA CYNTHIA M | Chief Operating Officer | 02/27/2017 | 13,500 |
BUTITTA CYNTHIA M | Chief Operating Officer | 03/01/2017 | 38,991 |
BUTITTA CYNTHIA M | Chief Operating Officer | 02/27/2017 | 544,178 |
BUTITTA CYNTHIA M | Chief Operating Officer | 03/01/2017 | 2,312,004 |
Wiezorek Jeffrey | SVP Clinical Development | 02/01/2017 | 10,335 |
Wiezorek Jeffrey | SVP Clinical Development | 02/01/2017 | 76,820 |
BUTITTA CYNTHIA M | Chief Operating Officer | 01/31/2017 | 13,500 |
BUTITTA CYNTHIA M | Chief Operating Officer | 01/31/2017 | 505,562 |
Wiezorek Jeffrey | SVP Clinical Development | 01/06/2017 | 10,335 |
Wiezorek Jeffrey | SVP Clinical Development | 01/06/2017 | 75,000 |
BUTITTA CYNTHIA M | Chief Operating Officer | 01/06/2017 | 13,500 |
BUTITTA CYNTHIA M | Chief Operating Officer | 01/06/2017 | 501,289 |
Wiezorek Jeffrey | SVP Clinical Development | 12/20/2016 | 36,416 |
Tomasello Shawn | Chief Commercial Officer | 12/20/2016 | 249,265 |
Kim Helen Susan | EVP, Business Development | 12/20/2016 | 47,605 |
Chang David D | EVP, R&D, Chief Medical Off. | 12/20/2016 | 90,938 |
BUTITTA CYNTHIA M | Chief Operating Officer | 12/20/2016 | 126,235 |
Belldegrun Arie | Chairman, President and CEO | 12/20/2016 | 177,654 |
Wiezorek Jeffrey | SVP Clinical Development | 12/01/2016 | 10,335 |
Wiezorek Jeffrey | SVP Clinical Development | 12/01/2016 | 76,134 |
BUTITTA CYNTHIA M | Chief Operating Officer | 11/25/2016 | 13,500 |
BUTITTA CYNTHIA M | Chief Operating Officer | 11/25/2016 | 504,015 |
BUTITTA CYNTHIA M | Chief Operating Officer | 11/10/2016 | 13,500 |
BUTITTA CYNTHIA M | Chief Operating Officer | 11/10/2016 | 506,466 |
Wiezorek Jeffrey | SVP Clinical Development | 11/10/2016 | 10,335 |
Wiezorek Jeffrey | SVP Clinical Development | 11/10/2016 | 75,270 |
Wiezorek Jeffrey | SVP Clinical Development | 10/03/2016 | 10,335 |
Wiezorek Jeffrey | SVP Clinical Development | 10/03/2016 | 82,214 |
BUTITTA CYNTHIA M | Chief Operating Officer | 09/26/2016 | 13,500 |
BUTITTA CYNTHIA M | Chief Operating Officer | 09/26/2016 | 541,300 |
Wiezorek Jeffrey | SVP Clinical Development | 09/01/2016 | 10,335 |
Wiezorek Jeffrey | SVP Clinical Development | 09/01/2016 | 87,362 |
BUTITTA CYNTHIA M | Chief Operating Officer | 08/25/2016 | 13,500 |
BUTITTA CYNTHIA M | Chief Operating Officer | 08/25/2016 | 582,775 |
Kim Helen Susan | EVP, Business Development | 08/15/2016 | 123,432 |
Kim Helen Susan | EVP, Business Development | 08/12/2016 | 1,722,905 |
Kim Helen Susan | EVP, Business Development | 08/12/2016 | 2,012,596 |
Kim Helen Susan | EVP, Business Development | 08/15/2016 | 151,229 |
Wiezorek Jeffrey | SVP Clinical Development | 08/01/2016 | 10,335 |
Wiezorek Jeffrey | SVP Clinical Development | 08/01/2016 | 85,343 |
BUTITTA CYNTHIA M | Chief Operating Officer | 07/25/2016 | 13,500 |
BUTITTA CYNTHIA M | Chief Operating Officer | 07/25/2016 | 509,350 |
Wiezorek Jeffrey | SVP Clinical Development | 07/01/2016 | 10,335 |
Wiezorek Jeffrey | SVP Clinical Development | 07/01/2016 | 75,007 |
BUTITTA CYNTHIA M | Chief Operating Officer | 06/27/2016 | 13,500 |
BUTITTA CYNTHIA M | Chief Operating Officer | 06/23/2016 | 13,500 |
BUTITTA CYNTHIA M | Chief Operating Officer | 06/27/2016 | 501,484 |
BUTITTA CYNTHIA M | Chief Operating Officer | 06/23/2016 | 512,754 |
DOUMANI ROY | Director | 06/06/2016 | 233,516 |
DOUMANI ROY | Director | 06/06/2016 | 579,065 |
Wiezorek Jeffrey | SVP Clinical Development | 06/01/2016 | 10,335 |
Wiezorek Jeffrey | SVP Clinical Development | 05/31/2016 | 10,335 |
Wiezorek Jeffrey | SVP Clinical Development | 06/01/2016 | 76,949 |
Wiezorek Jeffrey | SVP Clinical Development | 05/31/2016 | 75,000 |
BUTITTA CYNTHIA M | COO and CFO | 04/04/2016 | 13,500 |
BUTITTA CYNTHIA M | COO and CFO | 04/04/2016 | 500,000 |
Wiezorek Jeffrey | SVP Clinical Development | 03/15/2016 | 62,010 |
Wiezorek Jeffrey | SVP Clinical Development | 03/15/2016 | 403,943 |
Sproule Rizwana F | VP Regulatory Affairs | 03/15/2016 | 11,475 |
Sproule Rizwana F | VP Regulatory Affairs | 03/15/2016 | 384,791 |
Roberts Margo R | Chief Scientific Officer | 03/15/2016 | 22,352 |
Roberts Margo R | Chief Scientific Officer | 03/15/2016 | 384,766 |
Roberts Margo R | Chief Scientific Officer | 02/17/2016 | 23,156 |
BUTITTA CYNTHIA M | COO and CFO | 03/01/2016 | 13,500 |
BUTITTA CYNTHIA M | COO and CFO | 03/01/2016 | 500,300 |
Roberts Margo R | Chief Scientific Officer | 02/17/2016 | 6,742 |
Roberts Margo R | Chief Scientific Officer | 02/17/2016 | 434,018 |
Sproule Rizwana F | VP Regulatory Affairs | 02/17/2016 | 12,915 |
Sproule Rizwana F | VP Regulatory Affairs | 02/17/2016 | 431,279 |
Wiezorek Jeffrey | SVP Clinical Development | 02/16/2016 | 62,010 |
Wiezorek Jeffrey | SVP Clinical Development | 02/16/2016 | 396,652 |
Roberts Margo R | Chief Scientific Officer | 02/12/2016 | 13,125 |
Roberts Margo R | Chief Scientific Officer | 02/12/2016 | 1,202,964 |
BUTITTA CYNTHIA M | COO and CFO | 02/02/2016 | 2,565 |
BUTITTA CYNTHIA M | COO and CFO | 02/02/2016 | 95,247 |
Better Marc | VP, Product Sciences | 02/01/2016 | 3,420 |
Better Marc | VP, Product Sciences | 02/01/2016 | 426,036 |
BUTITTA CYNTHIA M | COO and CFO | 01/27/2016 | 10,935 |
BUTITTA CYNTHIA M | COO and CFO | 01/27/2016 | 418,128 |
Wiezorek Jeffrey | SVP Clinical Development | 01/15/2016 | 62,010 |
Wiezorek Jeffrey | SVP Clinical Development | 01/15/2016 | 497,379 |
Sproule Rizwana F | VP Regulatory Affairs | 01/19/2016 | 3,735 |
Sproule Rizwana F | VP Regulatory Affairs | 01/15/2016 | 9,180 |
Sproule Rizwana F | VP Regulatory Affairs | 01/19/2016 | 155,242 |
Sproule Rizwana F | VP Regulatory Affairs | 01/15/2016 | 375,589 |
Roberts Margo R | Chief Scientific Officer | 01/15/2016 | 14,815 |
Roberts Margo R | Chief Scientific Officer | 01/15/2016 | 339,323 |
Better Marc | VP, Product Sciences | 01/04/2016 | 3,420 |
Better Marc | VP, Product Sciences | 01/04/2016 | 553,788 |
BUTITTA CYNTHIA M | COO and CFO | 12/28/2015 | 13,500 |
BUTITTA CYNTHIA M | COO and CFO | 12/28/2015 | 615,599 |
Wiezorek Jeffrey | SVP Clinical Development | 12/15/2015 | 62,010 |
Wiezorek Jeffrey | SVP Clinical Development | 12/15/2015 | 573,989 |
Roberts Margo R | Chief Scientific Officer | 12/15/2015 | 14,815 |
Roberts Margo R | Chief Scientific Officer | 12/15/2015 | 391,815 |
Sproule Rizwana F | VP Regulatory Affairs | 12/15/2015 | 12,915 |
Sproule Rizwana F | VP Regulatory Affairs | 12/15/2015 | 609,994 |
Better Marc | VP, Product Sciences | 12/01/2015 | 3,420 |
Better Marc | VP, Product Sciences | 12/01/2015 | 686,819 |
BUTITTA CYNTHIA M | COO and CFO | 11/27/2015 | 20,250 |
BUTITTA CYNTHIA M | COO and CFO | 11/27/2015 | 1,296,680 |
Roberts Margo R | Chief Scientific Officer | 11/16/2015 | 14,815 |
Roberts Margo R | Chief Scientific Officer | 11/16/2015 | 480,270 |
Wiezorek Jeffrey | SVP Clinical Development | 11/16/2015 | 62,010 |
Wiezorek Jeffrey | SVP Clinical Development | 11/16/2015 | 702,681 |
Sproule Rizwana F | VP Regulatory Affairs | 11/16/2015 | 12,915 |
Sproule Rizwana F | VP Regulatory Affairs | 11/16/2015 | 747,507 |
BUTITTA CYNTHIA M | COO and CFO | 11/10/2015 | 6,750 |
BUTITTA CYNTHIA M | COO and CFO | 11/10/2015 | 400,000 |
Chang David D | EVP, R&D, Chief Medical Off. | 11/10/2015 | 212,212 |
Chang David D | EVP, R&D, Chief Medical Off. | 11/10/2015 | 2,464,616 |
Better Marc | VP, Product Sciences | 11/02/2015 | 3,420 |
Better Marc | VP, Product Sciences | 11/02/2015 | 639,652 |
Chang David D | EVP, R&D, Chief Medical Off. | 11/02/2015 | 53,053 |
Chang David D | EVP, R&D, Chief Medical Off. | 11/02/2015 | 547,292 |
BUTITTA CYNTHIA M | COO and CFO | 10/27/2015 | 13,500 |
BUTITTA CYNTHIA M | COO and CFO | 10/27/2015 | 699,120 |
Sproule Rizwana F | VP Regulatory Affairs | 10/15/2015 | 12,915 |
Sproule Rizwana F | VP Regulatory Affairs | 10/15/2015 | 598,731 |
Wiezorek Jeffrey | SVP Clinical Development | 10/15/2015 | 62,010 |
Wiezorek Jeffrey | SVP Clinical Development | 10/15/2015 | 563,319 |
Roberts Margo R | Chief Scientific Officer | 10/15/2015 | 14,815 |
Roberts Margo R | Chief Scientific Officer | 10/15/2015 | 384,509 |
Chang David D | EVP, R&D, Chief Medical Off. | 10/01/2015 | 53,053 |
Chang David D | EVP, R&D, Chief Medical Off. | 10/01/2015 | 424,347 |
Better Marc | VP, Product Sciences | 10/01/2015 | 3,420 |
Better Marc | VP, Product Sciences | 10/01/2015 | 493,326 |
BUTITTA CYNTHIA M | COO and CFO | 09/28/2015 | 13,500 |
BUTITTA CYNTHIA M | COO and CFO | 09/28/2015 | 558,672 |
Wiezorek Jeffrey | VP Clinical Development | 09/15/2015 | 62,010 |
Wiezorek Jeffrey | VP Clinical Development | 09/15/2015 | 579,018 |
Sproule Rizwana F | VP Regulatory Affairs | 09/15/2015 | 12,915 |
Sproule Rizwana F | VP Regulatory Affairs | 09/15/2015 | 615,733 |
Roberts Margo R | Chief Scientific Officer | 09/15/2015 | 14,815 |
Roberts Margo R | Chief Scientific Officer | 09/15/2015 | 395,320 |
Chang David D | EVP, R&D, Chief Medical Off. | 09/08/2015 | 50,876 |
Chang David D | EVP, R&D, Chief Medical Off. | 09/03/2015 | 2,177 |
Chang David D | EVP, R&D, Chief Medical Off. | 09/08/2015 | 406,120 |
Chang David D | EVP, R&D, Chief Medical Off. | 09/03/2015 | 17,380 |
Better Marc | VP, Product Sciences | 09/01/2015 | 3,420 |
Better Marc | VP, Product Sciences | 09/01/2015 | 466,292 |
BUTITTA CYNTHIA M | COO and CFO | 08/27/2015 | 13,500 |
BUTITTA CYNTHIA M | COO and CFO | 08/27/2015 | 536,156 |
Wiezorek Jeffrey | VP Clinical Development | 08/17/2015 | 62,010 |
Wiezorek Jeffrey | VP Clinical Development | 08/17/2015 | 547,820 |
Sproule Rizwana F | VP Regulatory Affairs | 08/17/2015 | 12,915 |
Sproule Rizwana F | VP Regulatory Affairs | 08/17/2015 | 582,407 |
Roberts Margo R | Chief Scientific Officer | 08/17/2015 | 14,815 |
Roberts Margo R | Chief Scientific Officer | 08/17/2015 | 374,236 |
Better Marc | VP, Product Sciences | 08/03/2015 | 3,420 |
Better Marc | VP, Product Sciences | 08/03/2015 | 649,246 |
Chang David D | EVP, R&D, Chief Medical Off. | 08/03/2015 | 53,053 |
Chang David D | EVP, R&D, Chief Medical Off. | 08/03/2015 | 555,242 |
BUTITTA CYNTHIA M | COO and CFO | 07/27/2015 | 13,500 |
BUTITTA CYNTHIA M | COO and CFO | 07/27/2015 | 684,818 |
Roberts Margo R | Chief Scientific Officer | 07/15/2015 | 236,251 |
Roberts Margo R | Chief Scientific Officer | 07/15/2015 | 1,593,674 |
Wiezorek Jeffrey | VP Clinical Development | 07/15/2015 | 62,010 |
Wiezorek Jeffrey | VP Clinical Development | 07/15/2015 | 647,257 |
Sproule Rizwana F | VP Regulatory Affairs | 07/15/2015 | 12,915 |
Sproule Rizwana F | VP Regulatory Affairs | 07/15/2015 | 687,828 |
Better Marc | VP, Product Sciences | 07/01/2015 | 3,420 |
Better Marc | VP, Product Sciences | 07/01/2015 | 557,075 |
Chang David D | EVP, R&D, Chief Medical Off. | 07/01/2015 | 53,053 |
Chang David D | EVP, R&D, Chief Medical Off. | 07/01/2015 | 476,781 |
CHAMPSI FARAH | Director | 06/30/2015 | 41,403,802 |
BUTITTA CYNTHIA M | COO and CFO | 06/29/2015 | 13,500 |
BUTITTA CYNTHIA M | COO and CFO | 06/29/2015 | 596,542 |
Wiezorek Jeffrey | VP Clinical Development | 06/15/2015 | 62,010 |
Wiezorek Jeffrey | VP Clinical Development | 06/25/2014 | 68,000 |
Wiezorek Jeffrey | VP Clinical Development | 06/15/2015 | 513,031 |
Chang David D | EVP, R&D, Chief Medical Off. | 06/15/2015 | 53,053 |
Chang David D | EVP, R&D, Chief Medical Off. | 06/25/2014 | 68,000 |
Chang David D | EVP, R&D, Chief Medical Off. | 06/15/2015 | 438,749 |
Sproule Rizwana F | VP Regulatory Affairs | 06/15/2015 | 12,915 |
Sproule Rizwana F | VP Regulatory Affairs | 06/15/2015 | 545,168 |
Roberts Margo R | Chief Scientific Officer | 06/15/2015 | 6,037 |
Roberts Margo R | Chief Scientific Officer | 06/15/2015 | 491,497 |
Nussbaum Ran | Director | 06/02/2015 | 12,437,229 |
Nussbaum Ran | Director | 06/01/2015 | 4,469,230 |
Better Marc | VP, Product Sciences | 06/01/2015 | 3,420 |
Better Marc | VP, Product Sciences | 06/01/2015 | 491,421 |
BUTITTA CYNTHIA M | COO and CFO | 05/27/2015 | 13,500 |
BUTITTA CYNTHIA M | COO and CFO | 05/27/2015 | 505,934 |
Roberts Margo R | Chief Scientific Officer | 05/15/2015 | 6,037 |
Roberts Margo R | Chief Scientific Officer | 05/15/2015 | 432,709 |
Wiezorek Jeffrey | VP Clinical Development | 05/15/2015 | 62,010 |
Wiezorek Jeffrey | VP Clinical Development | 05/15/2015 | 451,339 |
Sproule Rizwana F | VP Regulatory Affairs | 05/15/2015 | 12,915 |
Sproule Rizwana F | VP Regulatory Affairs | 05/15/2015 | 479,867 |
Better Marc | VP, Product Sciences | 05/01/2015 | 3,420 |
Better Marc | VP, Product Sciences | 05/01/2015 | 456,451 |
BUTITTA CYNTHIA M | COO and CFO | 04/27/2015 | 13,500 |
BUTITTA CYNTHIA M | COO and CFO | 04/27/2015 | 597,624 |
Nussbaum Ran | Director | 03/30/2015 | 6,941,468 |
Nussbaum Ran | Director | 03/27/2015 | 4,769,020 |
Peacock Jonathan M | Director | 06/25/2014 | 1,010,014 |
CHAMPSI FARAH | Director | 06/25/2014 | 11,615,301 |
Load More Insider Transactions
BUYBACK ANNOUNCEMENT(S) FOR
LOADING...